Product Information
LEVETIRACETAM ER 750 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.2234 per EA under NDC 50228019060. Its NADAC has been published 276 times since Jun 23, 2021.
FDA first approved this application on Nov 27, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228019060
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA205130FDA Approved
11/27/2020
TE Code
AB
On Market Since
11/27/2020
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM ER 750 MG TABLET has been published 276 times since Jun 23, 2021, and over the history we have for it it has declined 62.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2234 per EA |
|---|---|
| All-time high | $0.5896 (Jul 14, 2021) |
| All-time low | $0.1819 (Nov 20, 2024) |
| 52-week high | $0.2657 |
| 52-week low | $0.2104 |
| Median price | $0.2857 |
| Average price | $0.3059 |
| Largest weekly change | +50.1% (Aug 21, 2024) |
| Weeks tracked | 276 |
| Tracking since | Jun 23, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levetiracetam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM ER 750 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.2234 per EA (NDC 50228019060), effective Sep 30, 2026.
How has the price of LEVETIRACETAM ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM ER 750 MG TABLET has declined 62.1%. It has been tracked across 276 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM ER 750 MG TABLET?
Since Jun 23, 2021, the NADAC for LEVETIRACETAM ER 750 MG TABLET has ranged from a low of $0.1819 (Nov 20, 2024) to a high of $0.5896 (Jul 14, 2021), with a median of $0.2857 per EA.
Are there cheaper alternatives to LEVETIRACETAM ER 750 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 750 MG TABLET, is $0.1092 per EA — about 51% below LEVETIRACETAM ER 750 MG TABLET.
Who manufactures LEVETIRACETAM ER 750 MG TABLET?
LEVETIRACETAM ER 750 MG TABLET (NDC 50228019060) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.